glp 1 approved GLP-1s Hims Inc. - Novo Nordisk's

Al-SadawiMAAslamFMTaoMAlsaiqaliMAlmasryIOFanRet alEffects of GLP-1 agonists on mortality and arrhythmias in patients with type II diabetes

doi:10.3389/fphar.2024.1461398 116

2,16 This study reported that liraglutide, a long-acting GLP-1 RA administered once daily, dramatically reduces the incidence of papilledema when used as a supplementary medication in managing idiopathic intracranial hypertension while demonstrating favorable trends in other clinical outcomes

It May Lower Cardiovascular Risk Some studies suggest that yerba mate can boost HDL (aka good) cholesterol and lower LDL (aka bad) cholesterol, total cholesterol, and triglyceridesin turn, potentially lowering cardiovascular risk in both healthy and moderately at-risk populations

Consult your healthcare provider for guidance specific to your situation.

Extending the findings from the UK cohort study, additional real-world data derived from the Taiwan National Health Insurance Databasewhich encompasses Asian populations characterized by lower gallstone prevalence, low-fat and high-fiber dietary patterns, and lower body mass indexalso documented an elevated risk of biliary-related diseases linked to GLP-1 RAs compared with SGLT-2 inhibitors [36]